Serologic Evidence of Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Veterinary Professional Exposed to an Infected Domestic Cat - Los Angeles County, California, December 2024-January 2025. [PDF]
Vaughan A +23 more
europepmc +1 more source
Development of a pandemic H5N1 influenza vaccine using MDCK suspension cells: A scalable and efficient production platform. [PDF]
Zhang S +6 more
europepmc +1 more source
A nanobody-based proteolysis-targeting chimera offers broad-spectrum protection against diverse influenza virus infections. [PDF]
Zhuang Y +16 more
europepmc +1 more source
Infection of ratites with clade 2.3.4.4b HPAIV H5N1: potential implications for zoonotic risk. [PDF]
Coombes HA +15 more
europepmc +1 more source
Reassortant High Pathogenicity Avian Influenza A(H5N1) Viruses During the Reemergence in Uruguay Suggest Increasing Genetic Diversity in South America. [PDF]
Marandino A +9 more
europepmc +1 more source
Influenza Risk Assessment Tool (IRAT)\u2014Virus Report
Date of Evaluation: April 2023Prepared by the CDC Influenza DivisionHuman infections with influenza A viruses that commonly circulate among animals are rare, and the likelihood of sustained human-to-human transmission of these viruses remains low [1,2 ...
core
Highly Pathogenic Avian Influenza A(H5N1) Virus RNA in Bovine Semen, California, USA, 2024. [PDF]
Lim A +8 more
europepmc +1 more source
Stability of influenza viruses in the milk of cows and sheep. [PDF]
Schafers J +19 more
europepmc +1 more source
Genotype Diversity of Highly Pathogenic Avian Influenza H5N1 Clade 2.3.4.4b in Pennsylvania Poultry During Disease Outbreak from April 2022 to March 2023. [PDF]
Tewari D +8 more
europepmc +1 more source
Population immunity to clade 2.3.4.4b H5N1 is dominated by anti-neuraminidase antibodies. [PDF]
Singh G +13 more
europepmc +1 more source

